Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice

Our results demonstrate that antisense inhibition of ENaC in airway epithelial cells could be an effective and safe approach for the prevention and reversal of lung symptoms in CF and potentially other inflammatory diseases of the lung.